OXCT1 promotes triple negative breast cancer immune escape via modulating succinylation modification of PGK1

Abstract Immunotherapy has made a breakthrough in triple negative breast cancer (TNBC). The aim of this study is to investigate the specific role and regulatory mechanism of 3-oxoacid CoA-transferase 1 (OXCT1) in influencing TNBC growth and immune escape induced by aerobic glycolysis. OXCT1-induced...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongchen Zhang, Min Ling, Yuheng Zhang, Qing Fang, Wanlong Wo, Xiaoai Lv
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-025-08433-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849761460104724480
author Hongchen Zhang
Min Ling
Yuheng Zhang
Qing Fang
Wanlong Wo
Xiaoai Lv
author_facet Hongchen Zhang
Min Ling
Yuheng Zhang
Qing Fang
Wanlong Wo
Xiaoai Lv
author_sort Hongchen Zhang
collection DOAJ
description Abstract Immunotherapy has made a breakthrough in triple negative breast cancer (TNBC). The aim of this study is to investigate the specific role and regulatory mechanism of 3-oxoacid CoA-transferase 1 (OXCT1) in influencing TNBC growth and immune escape induced by aerobic glycolysis. OXCT1-induced enhancement of TNBC cell proliferation and PD-L1 expression is reversed by 2-DG. After interference with OXCT1 in TNBC patient-derived organoids (PDOs), tumor cell proliferation and lactic acid secretion are attenuated, and T-cell killing is enhanced. OXCT1 correlates with phosphoglycerate kinase 1 (PGK1) protein expression in clinical TNBC samples. In vitro overexpression of OXCT1 has no significant effect on PGK1 mRNA expression, but increases the succinylation level of PGK1 K146 and its protein stability, while decreasing its ubiquitination. The H4K20me1 level in the OXCT1 promoter region is increased in TNBC tissues, and in vitro lysine methyltransferase 5 A (KMT5A) overexpression increases the H4K20me1 level in the OXCT1 promoter region to promote OXCT1 expression. In conclusion, OXCT1 interference reverses the KMT5A-induced enhancement of TNBC cell viability, proliferation, and PD-L1 expression. KMT5A promotes OXCT1 expression through histone methylation, and OXCT1 increases PGK1 protein stability through succinylation modification, thereby promoting aerobic glycolysis and immune escape in TNBC.
format Article
id doaj-art-4b4fb18daba04d2489c8f150fe777f3a
institution DOAJ
issn 2399-3642
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Communications Biology
spelling doaj-art-4b4fb18daba04d2489c8f150fe777f3a2025-08-20T03:06:01ZengNature PortfolioCommunications Biology2399-36422025-07-018111210.1038/s42003-025-08433-wOXCT1 promotes triple negative breast cancer immune escape via modulating succinylation modification of PGK1Hongchen Zhang0Min Ling1Yuheng Zhang2Qing Fang3Wanlong Wo4Xiaoai Lv5Department of Breast Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)Department of General Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)The First School of Clinical Medicine, Zhejiang Chinese Medical UniversityThe First School of Clinical Medicine, Zhejiang Chinese Medical UniversityThe First School of Clinical Medicine, Zhejiang Chinese Medical UniversityDepartment of Breast Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)Abstract Immunotherapy has made a breakthrough in triple negative breast cancer (TNBC). The aim of this study is to investigate the specific role and regulatory mechanism of 3-oxoacid CoA-transferase 1 (OXCT1) in influencing TNBC growth and immune escape induced by aerobic glycolysis. OXCT1-induced enhancement of TNBC cell proliferation and PD-L1 expression is reversed by 2-DG. After interference with OXCT1 in TNBC patient-derived organoids (PDOs), tumor cell proliferation and lactic acid secretion are attenuated, and T-cell killing is enhanced. OXCT1 correlates with phosphoglycerate kinase 1 (PGK1) protein expression in clinical TNBC samples. In vitro overexpression of OXCT1 has no significant effect on PGK1 mRNA expression, but increases the succinylation level of PGK1 K146 and its protein stability, while decreasing its ubiquitination. The H4K20me1 level in the OXCT1 promoter region is increased in TNBC tissues, and in vitro lysine methyltransferase 5 A (KMT5A) overexpression increases the H4K20me1 level in the OXCT1 promoter region to promote OXCT1 expression. In conclusion, OXCT1 interference reverses the KMT5A-induced enhancement of TNBC cell viability, proliferation, and PD-L1 expression. KMT5A promotes OXCT1 expression through histone methylation, and OXCT1 increases PGK1 protein stability through succinylation modification, thereby promoting aerobic glycolysis and immune escape in TNBC.https://doi.org/10.1038/s42003-025-08433-w
spellingShingle Hongchen Zhang
Min Ling
Yuheng Zhang
Qing Fang
Wanlong Wo
Xiaoai Lv
OXCT1 promotes triple negative breast cancer immune escape via modulating succinylation modification of PGK1
Communications Biology
title OXCT1 promotes triple negative breast cancer immune escape via modulating succinylation modification of PGK1
title_full OXCT1 promotes triple negative breast cancer immune escape via modulating succinylation modification of PGK1
title_fullStr OXCT1 promotes triple negative breast cancer immune escape via modulating succinylation modification of PGK1
title_full_unstemmed OXCT1 promotes triple negative breast cancer immune escape via modulating succinylation modification of PGK1
title_short OXCT1 promotes triple negative breast cancer immune escape via modulating succinylation modification of PGK1
title_sort oxct1 promotes triple negative breast cancer immune escape via modulating succinylation modification of pgk1
url https://doi.org/10.1038/s42003-025-08433-w
work_keys_str_mv AT hongchenzhang oxct1promotestriplenegativebreastcancerimmuneescapeviamodulatingsuccinylationmodificationofpgk1
AT minling oxct1promotestriplenegativebreastcancerimmuneescapeviamodulatingsuccinylationmodificationofpgk1
AT yuhengzhang oxct1promotestriplenegativebreastcancerimmuneescapeviamodulatingsuccinylationmodificationofpgk1
AT qingfang oxct1promotestriplenegativebreastcancerimmuneescapeviamodulatingsuccinylationmodificationofpgk1
AT wanlongwo oxct1promotestriplenegativebreastcancerimmuneescapeviamodulatingsuccinylationmodificationofpgk1
AT xiaoailv oxct1promotestriplenegativebreastcancerimmuneescapeviamodulatingsuccinylationmodificationofpgk1